ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
63 391,15
-0,78%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. OptimizeRx Corporation (OPRX)

  7. OptimizeRx Corporation (OPRX) Actualités

OPRX OptimizeRx Corporation

10,62
-0,08 (-0,75%)
03 Mai 2024 - Fermé
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
OptimizeRx Corporation OPRX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
-0,08 -0,75% 10,62 22:30:00
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
10,94 10,60 10,97 10,62 10,70
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
11/3/202422:04EDGAR2Form 8-K - Current report
06/3/202422:19EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202400:25EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202400:24EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202400:23EDGAR2Form 4 - Statement of changes in beneficial ownership of..
22/2/202400:22EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/2/202423:05EDGAR2Form SC 13G - Statement of acquisition of beneficial..
14/2/202400:16EDGAR2Form 4 - Statement of changes in beneficial ownership of..
26/1/202422:00EDGAR2Form 8-K - Current report
11/1/202423:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
09/1/202422:28EDGAR2Form 144 - Report of proposed sale of securities
05/1/202423:19EDGAR2Form 8-K/A - Current report: [Amend]
29/12/202323:30EDGAR2Form SC 13G - Statement of acquisition of beneficial..
28/11/202322:10EDGAR2Form SC 13G - Statement of acquisition of beneficial..
13/11/202320:32EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/11/202313:15EDGAR2Form 8-K - Current report
03/11/202315:49EDGAR2Form 4 - Statement of changes in beneficial ownership of..
30/10/202321:06EDGAR2Form 3 - Initial statement of beneficial ownership of..
25/10/202322:00EDGAR2Form 8-K - Current report
16/10/202322:31EDGAR2Form 8-K - Current report
12/10/202320:18EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202320:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202320:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202320:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
06/10/202320:47EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202315:31EDGAR2Form 4 - Statement of changes in beneficial ownership of..
18/8/202315:29EDGAR2Form 4 - Statement of changes in beneficial ownership of..
14/8/202322:31EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
14/8/202322:05EDGAR2Form 8-K - Current report
20/6/202314:00GLOBELifeMD Appoints William J. Febbo to its Board of Directors

Dernières Valeurs Consultées

NASDAQ
OPRX
OptimizeRx
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés